Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trialLore Vanderbeke, Nico Janssen, Dennis C. J. J. Bergmans et al.|Intensive Care Medicine|2021Cited by 98
Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trialPierre‐François Laterre, Anne-Aurore Duchambon, Peter Pickkers et al.|Intensive Care Medicine|2021Cited by 92
A multicenter, randomized, double-blind study of ulimorelin and metoclopramide in the treatment of critically ill patients with enteral feeding intolerance: PROMOTE trialDaren K. Heyland, Oscar Hoiting, María Luisa Bordejé et al.|Intensive Care Medicine|2019Cited by 38
Effect of Automated Closed-Loop Ventilation vs Protocolized Conventional Ventilation on Ventilator-Free Days in Critically Ill AdultsJante S. Sinnige, Tineke Winters, Laura A. Buiteman‐Kruizinga et al.|JAMA|2025Cited by 5